Form 4: AEye Director Luis Dussan Sells Shares Under 10b5-1 Trading Plan

Director Luis Dussan sold 6,000 shares of AEye, Inc. common stock on January 7, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Luis Dussan, a director at AEye, Inc., sold a total of 6,000 shares of common stock on January 7, 2025.
• The sales were executed under a Rule 10b5-1 trading plan adopted on June 13, 2024.
• The shares were sold at weighted average prices of $3.8137 and $3.8146 per share.
• The transactions reduced Dussan's direct holdings, but he still indirectly owns shares through various trusts.
• The Luis Dussan Trust holds 241,832 shares, the Jennifer Dussan Trust holds 33,000 shares, and the Luis Carlos Dussan Family Trust holds 12,402 shares.

Sentiment

Score: 5

Explanation: The document is neutral, reporting a routine transaction under a pre-arranged trading plan. There is no indication of positive or negative sentiment.

Negatives

• The sale of shares by a director could be perceived negatively by some investors.

Risks

• Sales by insiders can sometimes signal a lack of confidence in the company's future prospects, although this sale was under a pre-arranged plan.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. The use of a 10b5-1 plan is a common practice to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and the details provided are consistent with what is expected.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares without raising concerns about insider trading, and is used by many directors and officers of public companies.

Stakeholder Impact

• The sale of shares by a director may cause some concern among shareholders, but the pre-arranged nature of the sale mitigates this concern.

Key Dates

Keywords

insider trading, Form 4, stock sale, Rule 10b5-1, AEye, LIDR, Luis Dussan